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lntroduction
Pancreatic pseudocyst is a known complication of chronic and acute 
pancreatitis, and has been occasionally described as a complication of 
post-liver transplantation acute pancreatitis [1,2]. Acute pancreatitis may 
occur early after liver transplantation in the form of clinical pancreatitis 
with an incidence of 3%, or as biochemical pancreatitis (hyperamylasemia) 
in 13% of cases [3].
We here describe a case of pancreatic pseudocyst diagnosed two months 
after liver transplantation in a patient with no clinical or biochemical signs 
of acute pancreatitis, and who was not suffering from chronic pancreatitis. 
It is believed that a pre-existent subclinical Vater’s papilla dysfunction was 
the predisposing factor leading to this uncommon complication.
Case Report
A 53-year-old Caucasian man with post-hepatitis C cirrhosis (Child-
Pugh class C1O) underwent orthotopic liver transplantation in April 
2012. The pre-transplant radiological evaluation did not reveal any 
pancreatic or biliary abnormalities other than cholelithiasis. He had a high 
bilirubin level (total bilirubin 5.0 mg/dl; nv <1.4: direct bilirubin 1.3 mg/
dl; nv <0.4), but normal levels of gamma glutamyltranspeptidase (GGT) 
(34 U/L; nv 11-50) and alkaline phosphatase (ALP) (278 U/L; nv 98-279).
A whole liver transplant was performed using a standard technique. 
The surgical dissection of the hepatic hilum was free of complications. A 
right hepatic artery arising from the superior mesenteric artery was tied 
and arterial anastomosis was performed using the recipient’s confluence 
between the left hepatic and gastroduodenal arteries sutured to the graft’s 
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Pancreatic pseudocysts rarely complicate acute pancreatitis after liver transplantation. We describe a case of post-transplant pancreatic 
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Pancreatic pseudocyst may arise as a complication of OLT in the absence of postoperative acute pancreatitis or a history of chronic pancreatitis. 
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common hepatic artery. Biliary reconstruction consisted of an end-to-end 
T-tube choledocho-choledochostomy.
The immunosuppressive regimen included cyclosporine and standard 
steroids with a 1g intraoperative bolus followed by a postoperative 
recycling schedule and then 20 mg/day of prednisone. The steroids were 
progressively tapered and finally withdrawn at the end of the third month.
Cholangiography performed on postoperative day 7 before T-tube 
clamping revealed mild dilation of the recipient’s common bile duct, with 
a normal flow into the duodenum. No stenosis of the biliary anastomosis 
was observed. The pancreatic duct was also visible, and had a diameter of 
3-4 mm for a short tract (2-3 cm) in the cephalic portion of the pancreas. 
On the basis of the absence of any significant clinical or biochemical 
signs of cholestasis, no further diagnostic procedures were undertaken. 
The postoperative course was generally uneventful, and the patient was 
discharged 11 days after surgery.
Two months after surgery (June 2012), the patient reported acute 
abdominal and dorsal pain. Ultrasonography revealed a large fluid 
collection (diameter: 9 cm) between the left hepatic lobe and the pancreas. 
The results of laboratory  blood tests were normal, including liver 
enzymes, amylase and lipase, and white blood cells (WBC) count. The 
collection was percutaneously drained, and the subsequently positioned 
“pig-tail” drain led to an output of 1500 ml/day of purulent liquid during 
the first two days, after which it dislocated. Biochemical evaluation 
of the fluid revealed high concentrations of amylase (25891 U/L) and 
lipase (>10000 U/L), and abdominal computed tomography confirmed 
the diagnosis of a pancreatic pseudocyst. The day after the CT-scan, the 
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patient had fever and the culture of the drained fluid showed the  presence 
of Staphylococcus Aureus, which also grew in the bile obtained from the 
T-tube. The pseudocyst was eventually resected and the postoperative 
course was uneventful. The T-tube was successfully removed in December 
2012 after appropriate induction therapy against Staphylococcus aureus, 
which was again found in the bile culture.
In November 2012 and April 2013, there were  slight increases in liver 
enzyme levels (aspartate aminotransferase, AST 59 U/L; nv 3-37: alanine 
aminotransferase, ALT 63 U/L; nv 3-40: GGT 60 U/L, ALP 319 U/L and 
total bilirubin 0.9 mg/di), and percutaneous liver biopsies revealed the 
recurrence of hepatitis C with lshak’s index values of 7 and 11.
Antiviral alpha-interferon and ribavirin treatment was started in 
November 2013 and has led to negative serum HCV-RNA detections 
since March 2014, although mild alterations in hepatic enzyme levels 
persisted. The main side effects of alpha-interferon were general malaise 
and fever, and a marked reduction in the WBC count to about 2000/ul (nv 
4000-10000), with a neutrophil count of about 800/uL (nv 1800-7700).
In June 2014, the patient remained negative for HCV-RNA, but his liver 
enzyme levels increased, particularly those concerning cholestasis indices 
(GGT 618 U/L, ALP 847 U/L, total bilirubin 1.5 mg/dl, AST 109 U/L, ALP 
100 U/L). A further percutaneous liver biopsy did not reveal any signs 
of rejection or hepatitis C, but the presence of cholangiolar proliferation 
suggested biliary damage despite  the  absence  of  ultrasonography 
findings  of  biliary  dilation.  An  endoscopic retrograde cholangio-
pancreatography (ERCP) revealed findings of a normal hepatic biliary 
tree, a normally patent anastomosis site, and mild dilation of the distal 
common bile duct leading to delayed contrast medium drainage. However, 
as it also revealed a stenosis of Vater’s papilla, a wide sphincterotomy was 
performed that normalised the flow into the duodenum. The interferon 
dose was first reduced and then withdrawn in November 2014. At the last 
follow-up visit a slow decrease in the biochemical indices of cholestasis 
was observed (AST 44 U/L, ALT 47 U/L, GGT 295 U/L, ALP 707 U/L, 
total bilirubin 1.1 mg/dl), and the WBC count was restored (5500/ul, 
neutrophils 2700).
Discussion
Pancreatic pseudocyst is a well-known complication of both acute and 
chronic pancreatitis, and has also been described after liver transplantation 
[1,2]. Acute post-liver transplantation pancreatitis is a rare and potentially 
severe complication [1,3,4]. lt has been suggested that various factors may 
contribute to the pathogenesis of acute post-transplant pancreatitis [1], 
including extensive surgical dissection around the pancreas, prolonged 
veno-venous by-pass time leading to ischemic damage of the pancreas [5], 
and hepatitis B infection [1,6]. Furthermore, some drugs may also play 
a role in the pathogenesis of pancreatitis, including large intraoperative 
doses of furosemide, steroids or calcium chloride [3].
After undergoing liver transplantation, our patient showed no signs of 
acute pancreatitis and hyperamylasemia was never observed. However, 
although the operation was uneventful and characterised by a plain 
surgical dissection of the hepatic pedicle, the fact that the gastroduodenal 
artery was divided may have led to ischemic damage of the pancreas. 
In relation to the other possible contributing factors of post-transplant 
pancreatitis described in the literature, there were no differences between 
this patient and the majority of our other liver transplant patients: he 
received the standard 1g intraoperative bolus steroid dose and underwent 
the standard postoperative recycling schedule postoperatively, without 
high doses of furosemide or calcium chloride.
It has been observed that chronic pancreatitis may cause sub-clinical 
common bile duct stenosis after liver transplantation in patients with 
alcoholic cirrhosis [7], and that such patients should therefore be carefully 
investigated intraoperatively in order to detect any pre-existing biliary 
stenosis. Our patient did not report a history of abdominal pain or alcohol 
abuse, and our preoperative radiological evaluations did not reveal the 
presence of biliary tract stenosis or dilation, pancreatic abnormalities 
such as chronic pancreatitis, or any pre-existent pancreatic cystic lesions. 
However, the biochemical diagnosis of  mechanical cholestasis in cirrhotic 
patients may be difficult because of  the limited accuracy of liver function 
tests: for example, our patient had high bilirubin levels but normal 
functional cholestasis index values.
Our surgical evaluation of the pancreas did not reveal any abnormality 
and the intraoperative cholangiogram only showed a mild dilation 
of the native common bile duct. However, the patient was affected by 
stones occluding Hartmann’s pouch, and it is known that a functional 
enlargement of the common bile duct may be caused by chronic 
gallbladder dysfunction.
The final etiology of the cholestasis observed in our case is probably 
related to a dysfunction in Vater’s papilla that rapidly progressed after 
transplantation [8]. The ERCP performed two years after transplantation 
showed a narrowed peri-ampullary tract and delayed contrast medium 
drainage from the common bile duct. The post-transplantation 
induction of  an immunodeficient status and the presence of a T-tube 
inside the biliary system can lead to cholangitis [9], which may have 
been rapidly precipitated by the pre-existent ampullary dysfunction. 
The pathogenesis of the large pancreatic pseudocyst detected very early 
after the liver transplantation can therefore be attributed to a surgically 
induced ischemic pancreatic injury associated with bacterial infection and 
pancreatic excretion impairment. This last was probably due to a Vater’s 
papilla dysfunction that persisted after the treatment of the pseudocyst 
and subsequently worsened because  of recurrent  subclinical  biliary 
infections. The cholestatic clinical presentation was finally explained 
by the recurrent cholangitis, which is a common late post-transplant 
complication that frequently has some specific histological picture [10]. 
We believe that the cholangitis was secondary to the combination of 
immunosuppression and interferon-related leukopenia in the presence of 
impaired bile outflow due to Vater’s papilla dysfunction.
In conclusion, pancreatic pseudocysts may arise as a complication 
of liver transplantation even in the absence of postoperative acute 
pancreatitis or a history of chronic pancreatitis. In our case, it is suspected 
that a Vater’s papilla dysfunction played a role in the etiology of both the 
early pancreatic pseudocyst and the late cholestasis.
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